Synthetica (China) Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Synthetica (China) General Information

Description

Developer of live bacterial medicines designed for the treatment of tumors and other diseases. The company's technology utilizes gene circuits and precise regulation of gene and payload expression, enabling medical industry users to deliver innovative bacterial drugs that meet specific treatment needs and improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Number 229, Gongchang Road, Zhenmei Community
  • Xinhu Street, Guangming District
  • Shenzhen, Guangdong 518000
  • China
+86 150
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5th Floor, Number 229, Gongchang Road, Zhenmei Community
  • Xinhu Street, Guangming District
  • Shenzhen, Guangdong 518000
  • China
+86 150

Synthetica (China) Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthetica (China) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 18-Nov-2025 Completed Generating Revenue
2. Secondary Transaction - Private 29-May-2025 Completed Generating Revenue
1. Early Stage VC (Series A) 16-May-2024 Completed Generating Revenue
To view Synthetica (China)’s complete valuation and funding history, request access »

Synthetica (China) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthetica (China) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
AVIC Trust Company Corporation Minority
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
Temasek Holdings Sovereign Wealth Fund Minority
To view Synthetica (China)’s complete investors history, request access »

Ready to get started?

Request a free trial

Synthetica (China) FAQs

  • When was Synthetica (China) founded?

    Synthetica (China) was founded in 2023.

  • Where is Synthetica (China) headquartered?

    Synthetica (China) is headquartered in Shenzhen, China.

  • What is the size of Synthetica (China)?

    Synthetica (China) has 26 total employees.

  • What industry is Synthetica (China) in?

    Synthetica (China)’s primary industry is Biotechnology.

  • Is Synthetica (China) a private or public company?

    Synthetica (China) is a Private company.

  • What is Synthetica (China)’s current revenue?

    The current revenue for Synthetica (China) is .

  • Who are Synthetica (China)’s investors?

    AVIC Trust Company, Boehringer Ingelheim Venture Fund, and Temasek Holdings have invested in Synthetica (China).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process